Licensed in Six States: Whether Each One Needs Its Own DEA Number

Does a license in each state require its own DEA registration?

Not by itself. DEA ties a registration to where you practice, and the rule is one registration for each principal place of business or professional practice at one general physical location where controlled substances are dispensed 1Ref 1Drug Enforcement Administration (Code of Federal Regulations, Title 21, Part 1301) (2024).§ 1301.12 Separate registrations for separate locations.The base rule that a separate registration is required for each principal place of business or professional practice at one general physical location, and the exact text and same-State limit of the (b)(3) prescribing-only office exemption.. A license authorizes practice in a state. A practice location in that state is what triggers a registration there, and six licenses without six locations do not trigger six registrations.

DEA has answered this question in its own words. In the Registration Q&A entry dated November 2, 2020, the agency says a practitioner who maintains a professional practice location in more than one state has, for registration purposes, a principal place of business in each of them, and that consequently DEA requires a separate registration in each state 2Ref 2U.S. Drug Enforcement Administration, Diversion Control Division (2026).Registration Q&A (Questions & Answers — Registration).DEA's stated position that a practitioner with a professional practice location in more than one state has a principal place of business in each and needs a separate registration in each, that state controlled-substance authorization must come first, and that one registration does not reach nationwide.. The page also states that its contents do not have the force and effect of law. The authorities it points to, 21 U.S.C. 822(e)(1) and 21 CFR 1301.12(a), do.

State authority comes first in the sequence. The same answer instructs the practitioner to first obtain authorization to handle controlled substances in each state where he or she has an office 2Ref 2U.S. Drug Enforcement Administration, Diversion Control Division (2026).Registration Q&A (Questions & Answers — Registration).DEA's stated position that a practitioner with a professional practice location in more than one state has a principal place of business in each and needs a separate registration in each, that state controlled-substance authorization must come first, and that one registration does not reach nationwide., so the state permission comes first and the federal application follows it.

But the federal number is not a national one. Asked whether a single registration lets a practitioner prescribe anywhere in the United States, DEA answers no, because state authority confers rights and privileges only within the issuing state 2Ref 2U.S. Drug Enforcement Administration, Diversion Control Division (2026).Registration Q&A (Questions & Answers — Registration).DEA's stated position that a practitioner with a professional practice location in more than one state has a principal place of business in each and needs a separate registration in each, that state controlled-substance authorization must come first, and that one registration does not reach nationwide.. Every question about DEA registrations across state lines starts from that sentence.

The one exemption, and why it stops at the state line

There is an exemption for an office where you only prescribe, and it stops at the state line. 21 CFR 1301.12(b)(3) exempts an office used by a practitioner who is registered at another location in the same State in which he or she practices, where controlled substances are prescribed but neither administered nor otherwise dispensed as a regular part of practice, and where no supplies of controlled substances are maintained 1Ref 1Drug Enforcement Administration (Code of Federal Regulations, Title 21, Part 1301) (2024).§ 1301.12 Separate registrations for separate locations.The base rule that a separate registration is required for each principal place of business or professional practice at one general physical location, and the exact text and same-State limit of the (b)(3) prescribing-only office exemption..

Read the parenthetical closely, because it carries the whole limit: registered at another location in the same State. A second office inside a state where you already hold a registration can ride on that registration, as long as you keep no supply and neither administer nor dispense there.

An office in the state next door has no registration to ride on. That is why a second office and a first office in a new state get different answers from the same regulation, and why the exemption never scales into a multi-state telehealth practice.

What the telehealth rules in force do and do not waive

They waive the in-person evaluation, and they waive nothing about registration. As of September 1, 2026, 21 CFR 1307.41 authorizes a DEA-registered practitioner to prescribe Schedule II through V controlled substances by telemedicine without having conducted a prior in-person medical evaluation, during the period May 12, 2023 through December 31, 2026, if all four conditions in subsection (c) are met 3Ref 3Drug Enforcement Administration (Code of Federal Regulations, Title 21, Part 1307) (2026).§ 1307.41 Temporary extension of certain COVID-19 telemedicine flexibilities for prescription of controlled medications.The telemedicine flexibility in force on 2026-09-01: a DEA-registered practitioner may prescribe Schedule II through V controlled substances without a prior in-person evaluation through December 31, 2026 under four conditions, and the section's own sunset date..

The phrase doing the work is DEA-registered practitioner. The flexibility begins where a registration already exists and says nothing about how many of them you hold.

The version in force arrived as the fourth temporary extension, published December 31, 2025 at 90 FR 61301 under Docket No. DEA-407 and effective January 1, 2026 through December 31, 2026 4Ref 4Drug Enforcement Administration, U.S. Department of Justice; Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services (2025).Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications.The dates and citation of the fourth temporary extension (90 FR 61301, effective January 1, 2026 through December 31, 2026), that it amends only 21 CFR 1307.41 and 42 CFR 12.1, and that the Special Registration rulemaking was pending with more than 6,475 comments received.. It amends 21 CFR 1307.41 and 42 CFR 12.1 and nothing else. No registration requirement moved when it landed.

The date on that paragraph matters. The section sunsets December 31, 2026 by its own terms, so every statement about telehealth prescribing on this page, and on any other page, describes a rule with an expiry printed inside it.

The question the current federal text leaves open

Whether a telehealth-only prescriber with no office in the patient's state needs a registration in that state is not settled by any of the documents above. DEA's Q&A answers the case of a practitioner who maintains a practice location in each state, which is the border-practice question. The telemedicine section is silent on registration count. The one federal text that ties a registration to the patient's location is a proposal.

Hold a professional practice location in six states and DEA's stated position reaches you directly, and the count is six 2Ref 2U.S. Drug Enforcement Administration, Diversion Control Division (2026).Registration Q&A (Questions & Answers — Registration).DEA's stated position that a practitioner with a professional practice location in more than one state has a principal place of business in each and needs a separate registration in each, that state controlled-substance authorization must come first, and that one registration does not reach nationwide.. See patients in six states from a single location and the federal text quoted here does not settle your case. The answer available today comes from each state's board, your malpractice carrier, and counsel who reads DEA guidance regularly.

Ask those questions in writing and keep the replies in the registration file. A written answer from a board is what you will want if the question is ever asked back.

What DEA has proposed, written in the conditional

A proposed rule would answer the telehealth question by adding registrations rather than removing them. DEA's notice of proposed rulemaking of January 17, 2025, published at 90 FR 6541, would create three types of Special Registration for telemedicine along with an ancillary State Telemedicine Registration, issued by DEA, for each state in which a telemedicine patient is located 5Ref 5Drug Enforcement Administration, U.S. Department of Justice (2025).Special Registrations for Telemedicine and Limited State Telemedicine Registrations.What the January 17, 2025 proposed rule would require of a multi-state telehealth prescriber: three types of Special Registration, a DEA-issued State Telemedicine Registration for each state where a telemedicine patient is located, the proposed $888 Special Registration fee and the discounted $50 per-state clinician registration on a three-year cycle, over a conventional 21 U.S.C. 823(g) registration. Written in the conditional throughout..

Under that proposal a clinician practitioner would hold three things at once: the conventional registration under 21 U.S.C. 823(g), a Special Registration proposed at $888, and a State Telemedicine Registration for each state where telemedicine patients are treated. That per-state registration is discounted to $50 on a three-year cycle 5Ref 5Drug Enforcement Administration, U.S. Department of Justice (2025).Special Registrations for Telemedicine and Limited State Telemedicine Registrations.What the January 17, 2025 proposed rule would require of a multi-state telehealth prescriber: three types of Special Registration, a DEA-issued State Telemedicine Registration for each state where a telemedicine patient is located, the proposed $888 Special Registration fee and the discounted $50 per-state clinician registration on a three-year cycle, over a conventional 21 U.S.C. 823(g) registration. Written in the conditional throughout..

It was still a proposal on September 1, 2026. The fourth extension records the rulemaking as pending with more than 6,475 comments received 4Ref 4Drug Enforcement Administration, U.S. Department of Justice; Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services (2025).Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications.The dates and citation of the fourth temporary extension (90 FR 61301, effective January 1, 2026 through December 31, 2026), that it amends only 21 CFR 1307.41 and 42 CFR 12.1, and that the Special Registration rulemaking was pending with more than 6,475 comments received., and nothing in the docket sets a date for a final rule.

Budget nothing from a proposed rule. Watch Docket No. DEA-407 instead, which is where the final rule will appear if it issues.

What each registration costs, and what the fee table omits

One practitioner registration costs $888 and runs three years. The fee table at 21 CFR 1301.13(e)(1) places practitioner registrants in its dispensing or instructing row, Schedules II through V, on Form 224 for a new application and Form 224a for renewal 6Ref 6Drug Enforcement Administration (Code of Federal Regulations, Title 21, Part 1301) (2024).§ 1301.13 Application for registration; time for application; expiration date; registration for independent activities; application forms, fees, contents and signature; coincident activities.The $888 fee and three-year term for one practitioner registration in the dispensing or instructing row of the fee table, and the Form 224 / 224a designation.. A nurse practitioner files as a mid-level practitioner, on the same forms a physician uses 7Ref 7Drug Enforcement Administration, Diversion Control Division (2026).Diversion Control Division | Registration.Which forms a nurse practitioner files as a practitioner or mid-level practitioner, that applications and renewals are submitted online, and that a current email address is required because DEA sends its notices electronically..

That last row is arithmetic and nothing more. No source in this material publishes a multi-state total. The fee table itself does not say whether a registration added mid-cycle is prorated, or whether it expires on its own three-year clock or lines up with the ones you already hold. It also says nothing about what a state charges for its own controlled-substance permit where one is required. That permit is a separate application to a separate agency, and each board publishes its own fee.

Keep a current email address on every registration, because DEA sends its notices electronically 7Ref 7Drug Enforcement Administration, Diversion Control Division (2026).Diversion Control Division | Registration.Which forms a nurse practitioner files as a practitioner or mid-level practitioner, that applications and renewals are submitted online, and that a current email address is required because DEA sends its notices electronically.. A DEA renewal notice arrives per registration rather than per practitioner, so six registrations means six renewal cycles to calendar.

Working out the answer for your own six states

Start from locations and work back to licenses. Write down every state where you maintain a professional practice location, meaning an address where patients are seen or from which you practice, and set beside it the states where you hold only a license. The first list drives the registration count under DEA's stated position, and the second one does not 2Ref 2U.S. Drug Enforcement Administration, Diversion Control Division (2026).Registration Q&A (Questions & Answers — Registration).DEA's stated position that a practitioner with a professional practice location in more than one state has a principal place of business in each and needs a separate registration in each, that state controlled-substance authorization must come first, and that one registration does not reach nationwide..

1. Confirm the state controlled-substance authorization before the federal application, since DEA's own instruction is to obtain authorization to handle controlled substances in each state where you have an office 2Ref 2U.S. Drug Enforcement Administration, Diversion Control Division (2026).Registration Q&A (Questions & Answers — Registration).DEA's stated position that a practitioner with a professional practice location in more than one state has a principal place of business in each and needs a separate registration in each, that state controlled-substance authorization must come first, and that one registration does not reach nationwide.. Some states issue a separate controlled-substance permit alongside the professional license and some do not, and the board that issued your license is the authority on which yours does. 2. File Form 224 for each location that needs one, through DEA's online registration system 7Ref 7Drug Enforcement Administration, Diversion Control Division (2026).Diversion Control Division | Registration.Which forms a nurse practitioner files as a practitioner or mid-level practitioner, that applications and renewals are submitted online, and that a current email address is required because DEA sends its notices electronically.. 3. Update the registered address whenever a practice address changes. Updating a DEA registration address after leaving a group belongs here, in the same pass. 4. Sequence what follows once a number issues. The setup order after DEA approval reaches the prescribing software, the state prescription-monitoring account, and the pharmacies that will read the number off a prescription. 5. Re-read the telehealth position on a calendar rather than on rumor. The flexibility in force expires December 31, 2026 3Ref 3Drug Enforcement Administration (Code of Federal Regulations, Title 21, Part 1307) (2026).§ 1307.41 Temporary extension of certain COVID-19 telemedicine flexibilities for prescription of controlled medications.The telemedicine flexibility in force on 2026-09-01: a DEA-registered practitioner may prescribe Schedule II through V controlled substances without a prior in-person evaluation through December 31, 2026 under four conditions, and the section's own sunset date., and the Special Registration proposal was unfinished on September 1, 2026 5Ref 5Drug Enforcement Administration, U.S. Department of Justice (2025).Special Registrations for Telemedicine and Limited State Telemedicine Registrations.What the January 17, 2025 proposed rule would require of a multi-state telehealth prescriber: three types of Special Registration, a DEA-issued State Telemedicine Registration for each state where a telemedicine patient is located, the proposed $888 Special Registration fee and the discounted $50 per-state clinician registration on a three-year cycle, over a conventional 21 U.S.C. 823(g) registration. Written in the conditional throughout..

If the six states each hold an office, the answer is six and the work is six applications. If they hold only a license, ask the six boards and get the answers in writing before the first prescription leaves your desk.